These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17489854)

  • 21. No evidence for differential methylation of α-synuclein in leukocyte DNA of Parkinson's disease patients.
    Richter J; Appenzeller S; Ammerpohl O; Deuschl G; Paschen S; Brüggemann N; Klein C; Kuhlenbäumer G
    Mov Disord; 2012 Apr; 27(4):590-1. PubMed ID: 22262231
    [No Abstract]   [Full Text] [Related]  

  • 22. The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element.
    Friedlich AL; Tanzi RE; Rogers JT
    Mol Psychiatry; 2007 Mar; 12(3):222-3. PubMed ID: 17325711
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
    Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
    Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
    Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
    Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C; Lee SJ
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Contursi Family 20 Years Later: Intrafamilial Phenotypic Variability of the SNCA p.A53T Mutation.
    Ricciardi L; Petrucci S; Di Giuda D; Serra L; Spanò B; Sensi M; Ginevrino M; Cocciolillo F; Bozzali M; Valente EM; Fasano A
    Mov Disord; 2016 Feb; 31(2):257-8. PubMed ID: 26799529
    [No Abstract]   [Full Text] [Related]  

  • 27. The genetics and molecular biology of alpha-synuclein.
    Farrer M
    Handb Clin Neurol; 2008; 89():313-9. PubMed ID: 18631756
    [No Abstract]   [Full Text] [Related]  

  • 28. Is alpha-synuclein the culprit of the Parkinsonian neurodegeneration?
    Kirik D; Gai WP; Jensen PH
    Exp Neurol; 2008 Jan; 209(1):3-4. PubMed ID: 18179907
    [No Abstract]   [Full Text] [Related]  

  • 29. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.
    Stöckl M; Fischer P; Wanker E; Herrmann A
    J Mol Biol; 2008 Feb; 375(5):1394-404. PubMed ID: 18082181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T.
    Gerard M; Debyser Z; Desender L; Baert J; Brandt I; Baekelandt V; Engelborghs Y
    J Neurochem; 2008 Jul; 106(1):121-33. PubMed ID: 18346205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
    Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
    Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
    Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
    Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-synuclein: one key opens many locks.
    Tanner CM
    Mov Disord; 2013 Aug; 28(9):1176-8. PubMed ID: 23925937
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel α-synuclein missense mutation in Parkinson disease.
    Proukakis C; Dudzik CG; Brier T; MacKay DS; Cooper JM; Millhauser GL; Houlden H; Schapira AH
    Neurology; 2013 Mar; 80(11):1062-4. PubMed ID: 23427326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.
    Halliday GM; McCann H
    Exp Neurol; 2008 Jan; 209(1):12-21. PubMed ID: 17706644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical variability in Chinese families with Parkinson disease and SNCA duplication, including the shortest 139kb duplication.
    Du YJ; Shen Y; Wang YX; Sun YM; Liu FT; Chen C; Chen K; Zuo CT; Wu JJ; Wang J; An Y; Yu H
    Parkinsonism Relat Disord; 2019 Nov; 68():60-62. PubMed ID: 31621621
    [No Abstract]   [Full Text] [Related]  

  • 37. A new biomarker for Parkinson's disease?
    Williams-Gray CH
    Mov Disord; 2016 Jan; 31(1):42. PubMed ID: 26688186
    [No Abstract]   [Full Text] [Related]  

  • 38. [116C-G polymorphism of the alpha-synuclein gene in patients with Parkinson disease].
    Ramirez-Jirano LJ; Ruiz-Sandoval JL; Jiménez-Gil FJ; Ramírez-Vega J; Vargas-Frutos E; Gallegos-Arreola MP
    Salud Publica Mex; 2006; 48(4):289-90. PubMed ID: 16913451
    [No Abstract]   [Full Text] [Related]  

  • 39. Identifying genes in Parkinson disease: state of the art.
    Chew EG; Foo JN; Tan EK
    Med J Aust; 2018 May; 208(9):381-382. PubMed ID: 29764346
    [No Abstract]   [Full Text] [Related]  

  • 40. Secrets of the shaking palsy.
    Schnabel J
    Nature; 2010 Aug; 466(7310):S2-5. PubMed ID: 20739933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.